Health Canada has not evaluated these compounds for safety or efficacy in treating any medical condition
Restraints - High Cost of Therapy The high cost of therapy is a significant restraint for the GLP-1 receptor agonist market, limiting patient access and long-term adoption
If you have underlying health conditions or are on long-term medication, sharing this information helps in avoiding complications
It is the per se DUI law
Injection site reactions (redness, mild swelling) occur in 2535% of injections and are normal inflammatory responses that peak at 1224 hours and resolve within 48 hours
LEU+ILE+PRO-OH, VAL, C0, C2, C3, C3DC+C4OH, C5, C6DC, C8:1, C10, C12, and C14 were significantly higher when TSH increased